search
view_module view_stream
NOD-2-active carboxamide compounds as vaccine adjuvants
Technology No. 2019-001
NOD-2-active carboxamide compounds as vaccine adjuvants
Find out more
Lentivirus for keratinocyte immortalization and immortalized keratinocyte cell lines
Technology No. 2020-286
Lentivirus for keratinocyte immortalization and immortalized keratinocyte cell lines
Find out more
High-throughput screening assay for sickle cell disease drug discovery
Technology No. 2019-329
High-throughput screening assay for sickle cell disease drug discovery
Find out more
Mouse-derived FSHD muscle cell lines
Technology No. 2019-199
Mouse-derived FSHD muscle cell lines
Find out more
Small molecules with antiproliferative activity against pancreatic cancer cells
Technology No. 20160388
Small molecules with antiproliferative activity against pancreatic cancer cells
Find out more
Steerable magneto-photonic particles for targeted delivery and collection of light
Technology No. 2023-107
Steerable magneto-photonic particles for targeted delivery and collection of light
Find out more
AgRP-Derived melanocortin-5 receptor peptide antagonists
Technology No. 2020-161
AgRP-Derived melanocortin-5 receptor peptide antagonists
Find out more
Methods for Modifying Proteins and Peptides.
Technology No. 20180338
Methods for Modifying Proteins and Peptides.
Find out more
Pain therapy without the risk of respiratory depression, addiction or abuse
Technology No. 20160199
Pain therapy without the risk of respiratory depression, addiction or abuse
Find out more
Cell-free selection of site-specific polypeptide binders via tethering
Technology No. 20170034
Cell-free selection of site-specific polypeptide binders via tethering
Find out more
Compound with selective inhibition potential against P300 and CBT
Technology No. 2021-151
Compound with selective inhibition potential against P300 and CBT
Find out more
Live cell assay to quantify the activity of SARS-CoV-2 main protease, Mpro
Technology No. 2021-102
Live cell assay to quantify the activity of SARS-CoV-2 main protease, Mpro
Find out more
T cell receptors for engineered T cell therapy
Technology No. 2020-202
T cell receptors for engineered T cell therapy
Find out more
A process to make ultra-high purity urea at low cost by using enzymes
Technology No. 2020-129
A process to make ultra-high purity urea at low cost by using enzymes
Find out more
Nanominne-1: novel virus-like particle (nanoparticle) vaccines to prevent SARS-CoV-2 infections
Technology No. 2020-372
Nanominne-1: novel virus-like particle (nanoparticle) vaccines to prevent SARS-CoV-2 infections
Find out more
AGRP-derived melanocortin receptor ligands
Technology No. 20160310
AGRP-derived melanocortin receptor ligands
Find out more
Chimeric melanocortin receptor ligands
Technology No. 20160320
Chimeric melanocortin receptor ligands
Find out more
Selective melanocortin receptor ligands
Technology No. 20160305
Selective melanocortin receptor ligands
Find out more
Semi-solid polymer drug delivery system
Technology No. 20120102
Semi-solid polymer drug delivery system
Find out more
Novel anti-cancer agents that target the epigenetic reader protein
Technology No. 2021-055
Novel anti-cancer agents that target the epigenetic reader protein
Find out more
Assessing tumor behavior and response to therapy
Technology No. 20160224
Assessing tumor behavior and response to therapy
Find out more
Machine learning for early cancer detection
Technology No. 2019-197
Machine learning for early cancer detection
Find out more
Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction
Technology No. 20170362
Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction
Find out more
Fast and reliable neutralization antibodies assay for AAV gene therapy (2020-121)
Technology No. 2020-121
Fast and reliable neutralization antibodies assay for AAV gene therapy (2020-121)
Find out more
SARS-CoV-2 N-protein for use in COVID-19 serological assays (2020-323)
Technology No. 2020-323
SARS-CoV-2 N-protein for use in COVID-19 serological assays (2020-323)
Find out more
Pharmacological agents to prevent recurrent C. diff infection (20150362)
Technology No. 20150362
Pharmacological agents to prevent recurrent C. diff infection (20150362)
Find out more
Adenovirus Vector Generating System (20110090)
Technology No. 20110090
Adenovirus Vector Generating System (20110090)
Find out more
A method to genetically engineer monocytes (20180236)
Technology No. 20180236
A method to genetically engineer monocytes (20180236)
Find out more
Monoclonal Anti-FAP for cancer research and therapeutic development (2019-131)
Technology No. 2019-131
Monoclonal Anti-FAP for cancer research and therapeutic development (2019-131)
Find out more
Antagomir to prevent cardiac arrhythmia (2019-069)
Technology No. 2019-069
Antagomir to prevent cardiac arrhythmia (2019-069)
Find out more
A novel small molecule screening platform for tauopathies (2019-123)
Technology No. 2019-123
A novel small molecule screening platform for tauopathies (2019-123)
Find out more
Opioid and Analgesic Chemical Compound Library (z09208)
Technology No. z09208
Opioid and Analgesic Chemical Compound Library (z09208)
Find out more
Ritonavir Analog with Anticancer Activity
Technology No. z08020
Ritonavir Analog with Anticancer Activity
Find out more
Carcinoma Immunotoxin Targeting Epidermal Growth Factor and Interleukin-4 Receptors
Technology No. z07098
Carcinoma Immunotoxin Targeting Epidermal Growth Factor and Interleukin-4 Receptors
Find out more
Lupus Treatments Possible with Identification of High Risk Haplotype
Technology No. z06083
Lupus Treatments Possible with Identification of High Risk Haplotype
Find out more
Drug Resistant Tuberculosis Treatment
Technology No. z06066
Drug Resistant Tuberculosis Treatment
Find out more
Targeting uPAR Overexpression on Human Glioblastoma
Technology No. z01223
Targeting uPAR Overexpression on Human Glioblastoma
Find out more
Direct Application of Antibiotics to Middle Ear for Ear Infection Treatment
Technology No. z01159
Direct Application of Antibiotics to Middle Ear for Ear Infection Treatment
Find out more
Kappa Receptor Agonists and Delta Receptor Antagonists
Technology No. z01152
Kappa Receptor Agonists and Delta Receptor Antagonists
Find out more
Genetic Modification of Endostatin: An Anti-Angiogenic Therapeutic
Technology No. z00094
Genetic Modification of Endostatin: An Anti-Angiogenic Therapeutic
Find out more
Multimeric Immunotoxins for Cancer Treatment and Graft vs Host Disease
Technology No. z00021
Multimeric Immunotoxins for Cancer Treatment and Graft vs Host Disease
Find out more
More Stable and Potent Cyclic ADP-Ribose Analogs
Technology No. 99184
More Stable and Potent Cyclic ADP-Ribose Analogs
Find out more
Treating Neurodegenerative Diseases with Nicotine Receptor Ligands
Technology No. 99089
Treating Neurodegenerative Diseases with Nicotine Receptor Ligands
Find out more
Minnesota LIVING WITH HEART FAILURE® Questionnaire (MLHFQ)
Technology No. 94019
Minnesota LIVING WITH HEART FAILURE® Questionnaire (MLHFQ)
Find out more
Minnesota Solvation (MNSOL) Database
Technology No. 2020-340
Minnesota Solvation (MNSOL) Database
Find out more
S100A4 inhibitor “Minnetamide” for prostate cancer treatment
Technology No. 2020-242
S100A4 inhibitor “Minnetamide” for prostate cancer treatment
Find out more
Living with Pulmonary Hypertension Questionnaire (LPHQ)
Technology No. 2020-185
Living with Pulmonary Hypertension Questionnaire (LPHQ)
Find out more
Novel process to obtain large quantities of primary cells for transplantation
Technology No. 2020-057
Novel process to obtain large quantities of primary cells for transplantation
Find out more
Selective bromodomain protein inhibitors that reduce cancer cell viability
Technology No. 2019-343
Selective bromodomain protein inhibitors that reduce cancer cell viability
Find out more
Dental stem cells to treat spinal cord injury
Technology No. 2019-317
Dental stem cells to treat spinal cord injury
Find out more
Reduce contamination from grains and powdered food
Technology No. 2019-244-2020-030
Reduce contamination from grains and powdered food
Find out more
A synergistic therapy for multi-drug resistant cancers
Technology No. 2019-141
A synergistic therapy for multi-drug resistant cancers
Find out more
Novel anticancer compound that targets metabolic plasticity
Technology No. 2019-124
Novel anticancer compound that targets metabolic plasticity
Find out more
3D tumor models for accurate testing of therapeutics
Technology No. 2019-018
3D tumor models for accurate testing of therapeutics
Find out more
A TLR-2 stimulatory molecule for use as a vaccine adjuvant
Technology No. 20180382
A TLR-2 stimulatory molecule for use as a vaccine adjuvant
Find out more
Unique small molecule modulators of GPCRs
Technology No. 20180345
Unique small molecule modulators of GPCRs
Find out more
Antibody based treatment for Type 1 Diabetes
Technology No. 20180340
Antibody based treatment for Type 1 Diabetes
Find out more
Immunostimulatory conjugates for targeted delivery as adjuvants
Technology No. 20180330
Immunostimulatory conjugates for targeted delivery as adjuvants
Find out more
Drug Delivery Device for Oral Topical Medicine
Technology No. 20180269
Drug Delivery Device for Oral Topical Medicine
Find out more
Bioink composition suitable for creating cardiac tissues
Technology No. 20180234
Bioink composition suitable for creating cardiac tissues
Find out more
Novel small molecules for chemotherapy sensitization
Technology No. 20180203
Novel small molecules for chemotherapy sensitization
Find out more
Cost Effective Preparation of Highly Stable, Reusable Whole Cell Biocatalysts
Technology No. 20180127
Cost Effective Preparation of Highly Stable, Reusable Whole Cell Biocatalysts
Find out more
Assay to measure intrinsic efficiency of GPCR ligands
Technology No. 20180126
Assay to measure intrinsic efficiency of GPCR ligands
Find out more
MHC Class II Molecules with Enhanced Co-receptor Affinity
Technology No. 20180109
MHC Class II Molecules with Enhanced Co-receptor Affinity
Find out more
A novel chemotherapy drug with reduced patient side-effects
Technology No. 20180103
A novel chemotherapy drug with reduced patient side-effects
Find out more
Tosedostat (CHR-2797) as a Potential Analgesic
Technology No. 20180059
Tosedostat (CHR-2797) as a Potential Analgesic
Find out more
Engineering Human CD64 Chimeric Receptors for Immune Therapy
Technology No. 20180040
Engineering Human CD64 Chimeric Receptors for Immune Therapy
Find out more
Specific kinase biosensors to probe cancer metabolism
Technology No. 20170295
Specific kinase biosensors to probe cancer metabolism
Find out more
An approach to identify allosteric modulators of kinases
Technology No. 20170278
An approach to identify allosteric modulators of kinases
Find out more
Biased Unmatched Bivalent LigandsTargeting Asymmetrically Signaling GPCR Homodimers
Technology No. 20170276
Biased Unmatched Bivalent LigandsTargeting Asymmetrically Signaling GPCR Homodimers
Find out more
Probes for Biosynthesis of Bacterial Cell Wall
Technology No. 20170242-20170352
Probes for Biosynthesis of Bacterial Cell Wall
Find out more
Unique compounds to treat obesity
Technology No. 20170238
Unique compounds to treat obesity
Find out more
Bacterial Histidine Kinase Inhibitor
Technology No. 20170232
Bacterial Histidine Kinase Inhibitor
Find out more
Universal tyrosine kinase substrates
Technology No. 20170189
Universal tyrosine kinase substrates
Find out more
Solar UV-Induced Skin Cancer Inhibitor
Technology No. 20170106
Solar UV-Induced Skin Cancer Inhibitor
Find out more
Fluorescence-based Detection of Kinase Allostery for High-throughput Allosteric Inhibitor Discovery
Technology No. 20170040
Fluorescence-based Detection of Kinase Allostery for High-throughput Allosteric Inhibitor Discovery
Find out more
Adaptive Immune Response Stimulated with TLR8 and Dual TLR7/TLR8 Agonists
Technology No. 20160410-20170196
Adaptive Immune Response Stimulated with TLR8 and Dual TLR7/TLR8 Agonists
Find out more
Kinase assay to aid in development of therapeutics for acute myeloid leukemia
Technology No. 20160394
Kinase assay to aid in development of therapeutics for acute myeloid leukemia
Find out more
PDAC Treatment with High Antiproliferative Activity Against MiaPaca-2
Technology No. 20160388
PDAC Treatment with High Antiproliferative Activity Against MiaPaca-2
Find out more
Novel inhibitors of HINT1 to treat neuropathic pain and addiction
Technology No. 20160363
Novel inhibitors of HINT1 to treat neuropathic pain and addiction
Find out more
Optimizing Gene Editing in NK Cells for Therapy and Research
Technology No. 20160346
Optimizing Gene Editing in NK Cells for Therapy and Research
Find out more
Biosynthetic Route to Serofendic Acid
Technology No. 20160338
Biosynthetic Route to Serofendic Acid
Find out more
Efficient release of affinity-captured cells
Technology No. 20160236
Efficient release of affinity-captured cells
Find out more
Nonsurgical Method for Restoring Tooth Enamel
Technology No. 20160189
Nonsurgical Method for Restoring Tooth Enamel
Find out more
Peptide Activation of T Cells for Cancer Immunotherapy
Technology No. 20160174
Peptide Activation of T Cells for Cancer Immunotherapy
Find out more
Biomarker for Diagnosis of Aggressive Breast Cancer
Technology No. 20160149
Biomarker for Diagnosis of Aggressive Breast Cancer
Find out more
Improved Pertussis Vaccine
Technology No. 20160135
Improved Pertussis Vaccine
Find out more
Algorithm for Discovering Genetic Interactions in Genome-Wide Association Studies (BridGE)
Technology No. 20160109
Algorithm for Discovering Genetic Interactions in Genome-Wide Association Studies (BridGE)
Find out more
Live Attenuated Viral Vaccines
Technology No. 20160001
Live Attenuated Viral Vaccines
Find out more
Nucleic Acid Delivery to the Liver for Hemophilia and Lysosomal Storage Disease Treatment (20150339, Dr. Reineke)
Technology No. 20150339
Nucleic Acid Delivery to the Liver for Hemophilia and Lysosomal Storage Disease Treatment (20150339, Dr. Reineke)
Find out more
Improved Thiourea Catalysts (20150314, Dr. Steven Kass)
Technology No. 20150314
Improved Thiourea Catalysts (20150314, Dr. Steven Kass)
Find out more
HerdIn:Form(er): Mobile Questionnaire for Livestock Epidemiology Research (20150194, Dr. Andres Perez)
Technology No. 20150194
HerdIn:Form(er): Mobile Questionnaire for Livestock Epidemiology Research (20150194, Dr. Andres Perez)
Find out more
Midazolam Lysine Prodrug Rapid Delivery System (20150121, Dr. Ronald Siegel)
Technology No. 20150121
Midazolam Lysine Prodrug Rapid Delivery System (20150121, Dr. Ronald Siegel)
Find out more
Potent HIV Integrase Inhibitor (20150106, Dr. Zhengqiang Wang)
Technology No. 20150106
Potent HIV Integrase Inhibitor (20150106, Dr. Zhengqiang Wang)
Find out more
High-efficiency Pyrrole Synthesis (20150075, Dr. Ian Tonks)
Technology No. 20150075
High-efficiency Pyrrole Synthesis (20150075, Dr. Ian Tonks)
Find out more
Therapeutic compound for chronic inflammatory pain without dependence or tolerance (20140357, Dr. Philip Portoghese)
Technology No. 20140357
Therapeutic compound for chronic inflammatory pain without dependence or tolerance (20140357, Dr. Philip Portoghese)
Find out more
Circulating Tumor Cell Detection with New Reagents (20140299, Dr. Jayanth Panyam)
Technology No. 20140299
Circulating Tumor Cell Detection with New Reagents (20140299, Dr. Jayanth Panyam)
Find out more
Mesoporous Silica-coated Iron Oxide Nanoparticle (20140249, Dr. Christy Haynes)
Technology No. 20140249
Mesoporous Silica-coated Iron Oxide Nanoparticle (20140249, Dr. Christy Haynes)
Find out more
Biguanide Compounds for Estrogen Receptor Positive Breast Cancer Treatment (20140240, Dr. David Potter)
Technology No. 20140240
Biguanide Compounds for Estrogen Receptor Positive Breast Cancer Treatment (20140240, Dr. David Potter)
Find out more
Beta-Catenin Inhibitors
Technology No. 20140141
Beta-Catenin Inhibitors
Find out more
Protein Scaffold for Molecular Targeting Ligands (20140059, Dr. Benjamin Hackel)
Technology No. 20140059
Protein Scaffold for Molecular Targeting Ligands (20140059, Dr. Benjamin Hackel)
Find out more
Mesoporous silica nanoparticles with ultra high porosity
Technology No. 20140012
Mesoporous silica nanoparticles with ultra high porosity
Find out more
FRET Based Assay to Discover Modulators of RyR Calcium Channels (20130323, Dr. Razvan Cornea)
Technology No. 20130323
FRET Based Assay to Discover Modulators of RyR Calcium Channels (20130323, Dr. Razvan Cornea)
Find out more
Blood Sugar Regulation with D-serine (20130320, Dr. Amber Lockridge)
Technology No. 20130320
Blood Sugar Regulation with D-serine (20130320, Dr. Amber Lockridge)
Find out more
Prodrug with Enzyme Increases Absorption of Hydrophobic Drugs (20130297, Dr. Ronald Siegel)
Technology No. 20130297
Prodrug with Enzyme Increases Absorption of Hydrophobic Drugs (20130297, Dr. Ronald Siegel)
Find out more
Reagent for Dual Protein Labeling (20130255, Dr. Mark Distefano)
Technology No. 20130255
Reagent for Dual Protein Labeling (20130255, Dr. Mark Distefano)
Find out more
Improved SERCA Assay (20130193, Dr. David Thomas)
Technology No. 20130193-20140051
Improved SERCA Assay (20130193, Dr. David Thomas)
Find out more
Analgesics for Inflammatory Pain (20130119, Dr. Philip Portoghese)
Technology No. 20130119
Analgesics for Inflammatory Pain (20130119, Dr. Philip Portoghese)
Find out more
Aurora Kinase Inhibitors for Cancer Treatment (20120305, Dr. Zigang Dong)
Technology No. 20120305
Aurora Kinase Inhibitors for Cancer Treatment (20120305, Dr. Zigang Dong)
Find out more
Molecular Probe Measures Nucleosides and Differentiation of ATP and ADP (20120272, Dr. Valerie Pierre)
Technology No. 20120272
Molecular Probe Measures Nucleosides and Differentiation of ATP and ADP (20120272, Dr. Valerie Pierre)
Find out more
Enhancing Cardiac Function Using Short Protein Inhibiting DNAs and RNAs (20120271, Dr. Michael Bowser)
Technology No. 20120271
Enhancing Cardiac Function Using Short Protein Inhibiting DNAs and RNAs (20120271, Dr. Michael Bowser)
Find out more
Analogs of Cabergoline Lessen Side Effects (20120228, Dr. Peter Dosa)
Technology No. 20120228
Analogs of Cabergoline Lessen Side Effects (20120228, Dr. Peter Dosa)
Find out more
Functionalized Nanoparticles Provide More Effective Anticancer Drug Delivery (20120116, Dr. Jayanth Panyam)
Technology No. 20120116
Functionalized Nanoparticles Provide More Effective Anticancer Drug Delivery (20120116, Dr. Jayanth Panyam)
Find out more
Small Aromatic Molecule Synthesis at Ambient Conditions Using Diels-Alder Reactions and Benzyne Intermediates
Technology No. 20120115
Small Aromatic Molecule Synthesis at Ambient Conditions Using Diels-Alder Reactions and Benzyne Intermediates
Find out more
Controlled Drug Release with Drug Delivery System (20120102, Dr. Chun Wang)
Technology No. 20120102
Controlled Drug Release with Drug Delivery System (20120102, Dr. Chun Wang)
Find out more
Fractalkine Binding Aptamers for Drug Delivery (20120074, Dr. Efrosini Kokkoli)
Technology No. 20120074
Fractalkine Binding Aptamers for Drug Delivery (20120074, Dr. Efrosini Kokkoli)
Find out more
Monocarboxylate Transporter (MCT) Inhibitors to Treat Hypoxic Tumors (20120012)
Technology No. 20120012
Monocarboxylate Transporter (MCT) Inhibitors to Treat Hypoxic Tumors (20120012)
Find out more
Bacteriostatic Treatment for Staph Infections (20110209, Dr. Patrick Schlievert)
Technology No. 20110209
Bacteriostatic Treatment for Staph Infections (20110209, Dr. Patrick Schlievert)
Find out more
Generation of NK and Innate Lymphoid Cells from human stem cells (20110085, Dr. Michael Verneris)
Technology No. 20110085
Generation of NK and Innate Lymphoid Cells from human stem cells (20110085, Dr. Michael Verneris)
Find out more
Toxoid Vaccine for Antibiotic Resistant Staphylococcus aureus (20110070, Dr. Patrick Schlievert)
Technology No. 20110070
Toxoid Vaccine for Antibiotic Resistant Staphylococcus aureus (20110070, Dr. Patrick Schlievert)
Find out more
Cancer Treatment Uses Ornithine Decarboxylase Inhibitor (20110052, Dr. Zigang Dong, Dr. Ann Bode)
Technology No. 20110052
Cancer Treatment Uses Ornithine Decarboxylase Inhibitor (20110052, Dr. Zigang Dong, Dr. Ann Bode)
Find out more
Treating Carcinomas Using Immunotoxin Specific for Cancer Stem Cells (20110014, Dr. John Ohlfest)
Technology No. 20110014
Treating Carcinomas Using Immunotoxin Specific for Cancer Stem Cells (20110014, Dr. John Ohlfest)
Find out more
Cancer Vaccine Adjuvant: Annexin II (20100242)
Technology No. 20100242
Cancer Vaccine Adjuvant: Annexin II (20100242)
Find out more
Lysosomal Storage Disease Enzyme Delivery System (20100076)
Technology No. 20100076
Lysosomal Storage Disease Enzyme Delivery System (20100076)
Find out more
Category VIEW ALL
chevron_right
chevron_right
chevron_right
Biologics (39)
Biomarkers (37)
Biomaterials (12)
Biochemicals & Small Molecules (17)
Diagnostics & Imaging (153)
Health IT (40)
Human Health (204)
Industrial Biotech (41)
Medical Devices (164)
MRI & Spectroscopy (66)
Neuroscience (35)
Pharmaceuticals (124)
Medical Questionnaires (10)
Research Tools (141)
Therapeutics (72)
chevron_right
chevron_right
chevron_right